SFRP4 Expression Is Linked to Immune-Driven Fibrotic Conditions, Correlates with Skin and Lung Fibrosis in SSc and a Potential EMT Biomarker

por Tinazzi, Ilaria, Mulipa, Panji, Colato, Chiara, Abignano, Giuseppina, Ballarin, Andrea, Biasi, Domenico, Emery, Paul, Ross, Rebecca L., Del Galdo, Francesco
Publicado 2021

Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis

por Kondo, Masahiro, Suzuki, Tsuyoshi, Kawano, Yuko, Kojima, Shinji, Miyashiro, Masahiko, Matsumoto, Atsuhiro, Kania, Gabriela, Błyszczuk, Przemysław, Ross, Rebecca L., Mulipa, Panji, Del Galdo, Francesco, Zhang, Yun, Distler, Jörg H. W.
Publicado 2022

Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses

por Saleem, Benazir, Ross, Rebecca L, Bissell, Lesley-Anne, Aslam, Aamir, Mankia, Kulveer, Duquenne, Laurence, Corsadden, Diane, Carter, Clive, Hughes, Pam, Nadat, Fatima A, Mulipa, Panji, Lobb, Mark, Clarke, Brendan, Mbara, Katie, Morton, Ruth, Dibb, Sophie, Chowdhury, Rahaymin, Newton, Darren, Pike, Alexandra, Kakkar, Vishal, Savic, Sinisia, DelGaldo, Francesco, Emery, Paul
Publicado 2022